Clinical Trials Directory

Trials / Unknown

UnknownNCT01830998

Early Detection of Cognitive Dysfunction in Diabetes

Study of Cognitive Dysfunction and Diabetes

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Wuhan General Hospital of Guangzhou Military Command · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Accepted

Summary

The rate of cognitive decline due to ageing is increased 1.5-fold to 2.0-fold in individuals with type 2 diabetes.There are no established specific treatment measures to prevent or ameliorate cognitive impairments in patients with diabetes. we want to detecte early clinical dementia in diabete.

Detailed description

Clinically relevant cognitive decrements in relation to diabetes mainly occur during two crucial periods in life: the period of brain development in childhood, and the period when the brain undergoes neurodegenerative changes associated with ageing.Potential leads for treatment are to optimise glycaemic control and avoid and treat vascular risk factors.we want to detecte early clinical dementia in diabete by MMSE and Olfactory function.

Conditions

Timeline

Start date
2012-01-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2013-04-12
Last updated
2014-12-10

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT01830998. Inclusion in this directory is not an endorsement.